Advanced in COVID-19

Julien Pottecher

Strasbourg, FR 
Advanced in COVID-19
Strasbourg, FR 
OverviewLocationsClinical Research

Overview

Julien Pottecher practices in Strasbourg, France. Mr. Pottecher is rated as an Advanced expert by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Severe Acute Respiratory Syndrome (SARS), Thrombectomy, and Lung Transplant.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles and participated in 1 clinical trial in the study of COVID-19.

Gender
Male

Locations

Strasbourg, France
Other Locations
Paris, France
Nancy, France
CHU de Besançon
Besancon, France
1 Avenue Molière 67098 Strasbourg Cedex, Moliere, 67098, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Enrollment Status: Unknown
Publish Date: March 23, 2022
Intervention Type: Other
Study Phase: Not Applicable
Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients.
Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients.
Enrollment Status: Completed
Publish Date: January 05, 2022
Intervention Type: Combination product
Study Phase: Not Applicable
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury: the Prospective Randomized MUSIC-TCNV Trial.
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury: the Prospective Randomized MUSIC-TCNV Trial.
Enrollment Status: Terminated
Publish Date: November 17, 2021
Intervention Type: Other
Study Phase: Not Applicable
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Enrollment Status: Completed
Publish Date: August 19, 2021
Intervention Type: Drug
Study Drug: Human Immunoglobulin
Study Phase: Phase 3
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Enrollment Status: Completed
Publish Date: June 29, 2020
Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study
Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study
Enrollment Status: Unknown
Publish Date: August 01, 2018
Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.
Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.
Enrollment Status: Terminated
Publish Date: February 22, 2018
Intervention Type: Procedure
Study Phase: Not Applicable
View 6 Less Clinical Trials

143 Total Publications

Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial.
Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial.
Journal: American journal of respiratory and critical care medicine
Published: May 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pottecher's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile